The alveolar epithelial cell chemokine response to Pneumocystis requires adaptor molecule MyD88 and interleukin-1 receptor but not toll-like receptor 2 or 4

Infection and Immunity

Volumn 80, Issue 11, 2012, Pages 3912-3920

  Bello Irizarry, Sheila N ^a   Wang, Jing ^b   Olsen, Keith ^a   Gigliotti, Francis ^a,b   Wright, Terry W ^a,b  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; ADAPTOR PROTEIN TRIF; CXCL2 CHEMOKINE; INTERLEUKIN 1 RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOID DIFFERENTIATION FACTOR 88; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; IN VITRO STUDY; LUNG ALVEOLUS EPITHELIUM; MOUSE; NONHUMAN; PNEUMOCYSTIS; PNEUMOCYSTOSIS; PRIORITY JOURNAL;

ANIMALS; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIAL CELLS; MICE; MICE, INBRED C57BL; MICE, SCID; MYELOID DIFFERENTIATION FACTOR 88; PNEUMOCYSTIS; PNEUMONIA, PNEUMOCYSTIS; PULMONARY ALVEOLI; RECEPTORS, INTERLEUKIN-1; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

EID: 84867591881     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00708-12     Document Type: Article

References (40)

1. Adachi O, et al. 1998. Targeted disruption of the MyD88 gene results in loss of IL-1-and IL-18-mediated function. Immunity 9:143-150.
2. Arias MA, et al. 2007. Mycobacterium tuberculosis antigens specifically modulate CCR2 and MCP-1/CCL2 on lymphoid cells from human pulmonary hilar lymph nodes. J. Immunol. 179:8381-8391.
3. Armstrong L, et al. 2004. Expression of functional Toll-like receptor-2 and -4 on alveolar epithelial cells. Am. J. Respir. Cell Mol. Biol. 31:241-245.
4. Balamayooran G, Batra S, Balamayooran T, Cai S, Jeyaseelan S. 2011. Monocyte chemoattractant protein 1 regulates pulmonary host defense via neutrophil recruitment during Escherichia coli infection. Infect. Immun. 79:2567-2577.
5. Benfield TL, Lundgren B, Shelhamer JH, Lundgren JD. 1999. Pneumocystis carinii major surface glycoprotein induces interleukin-8 and monocyte chemoattractant protein-1 release from a human alveolar epithelial cell line. Eur. J. Clin. Invest. 29:717-722.
6. Chen W, et al. 1992. Interleukin 1: an important mediator of host resistance against Pneumocystis carinii. J. Exp. Med. 176:713-718.
7. Ding K, et al. 2005. Impaired recognition by Toll-like receptor 4 is responsible for exacerbated murine Pneumocystis pneumonia. Microbes Infect. 7:195-203.
8. Evans SE, et al. 2005. Pneumocystis cell wall beta-glucans stimulate alveolar epithelial cell chemokine generation through nuclear factor-kappaBdependent mechanisms. Am. J. Respir. Cell Mol. Biol. 32:490-497.
9. Gentry M, et al. 2007. Role of primary human alveolar epithelial cells in host defense against Francisella tularensis infection. Infect. Immun. 75: 3969-3978.
10. Gigliotti F, Crow EL, Bhagwat SP, Wright TW. 2006. Sensitized CD8+ T cells fail to control organism burden but accelerate the onset of lung injury during Pneumocystis carinii pneumonia. Infect. Immun. 74:6310-6316.
11. Hahn PY, et al. 2003. Pneumocystis carinii cell wall beta-glucan induces release of macrophage inflammatory protein-2 from alveolar epithelial cells via a lactosylceramide-mediated mechanism. J. Biol. Chem. 278:2043-2050.
12. Jones CL, Weiss DS. 2011. TLR2 signaling contributes to rapid inflammasome activation during F. novicida infection. PLoS One 6:e20609. doi: 10.1371/journal.pone.0020609.
13. Kaplan JE, et al. 2000. Epidemiology of human immunodeficiency virusassociated opportunistic infections in the United States in the era of highly active antiretroviral therapy. Clin. Infect. Dis. 30(Suppl 1):S5-S14.
14. Kaur N, Mahl TC. 2007. Pneumocystis jirovecii (carinii) pneumonia after infliximab therapy: a review of 84 cases. Dig. Dis. Sci. 52:1481-1484.
15. Kawai T, Akira S. 2007. TLR signaling. Semin. Immunol. 19:24-32.
16. Kroe DM, Kirsch CM, Jensen WA. 1997. Diagnostic strategies for Pneumocystis carinii pneumonia. Semin. Respir. Infect. 12:70-78.
17. Lebron F, Vassallo R, Puri V, Limper AH. 2003. Pneumocystis carinii cell wall beta-glucans initiate macrophage inflammatory responses through NF-kappaB activation. J. Biol. Chem. 278:25001-25008.
18. Limper AH. 1991. Parasitic adherence and host responses in the development of Pneumocystis carinii pneumonia. Semin. Respir. Infect. 6:19-26.
19. Limper AH, Offord KP, Smith TF, Martin WJ, II. 1989. Pneumocystis carinii pneumonia. Differences in lung parasite number and inflammation in patients with and without AIDS. Am. Rev. Respir. Dis. 140:1204-1209.
20. Maus UA, et al. 2005. CCR2-positive monocytes recruited to inflamed lungs downregulate local CCL2 chemokine levels. Am. J. Physiol. Lung Cell. Mol. Physiol. 288:L350-L358.
21. Morris A, et al. 2004. Current epidemiology of Pneumocystis pneumonia. Emerg. Infect. Dis. 10:1713-1720.
22. Morrison BE, Park SJ, Mooney JM, Mehrad B. 2003. Chemokinemediated recruitment of NK cells is a critical host defense mechanism in invasive aspergillosis. J. Clin. Invest. 112:1862-1870.
23. Netea MG, et al. 2009. Differential requirement for the activation of the inflammasome for processing and release of IL-1beta in monocytes and macrophages. Blood 113:2324-2335.
24. Netea MG, et al. 2010. IL-1beta processing in host defense: beyond the inflammasomes. PLoS Pathog. 6:e1000661. doi:10.1371/journal.ppat.1000661.
25. Norris KA, Morris A, Patil S, Fernandes E. 2006. Pneumocystis colonization, airway inflammation, and pulmonary function decline in acquired immunodeficiency syndrome. Immunol. Res. 36:175-187.
26. Pottratz ST. 1998. Pneumocystis carinii interactions with respiratory epithelium. Semin. Respir. Infect. 13:323-329.
27. Rice WR, et al. 2002. Maintenance of the mouse type II cell phenotype in vitro. Am. J. Physiol. Lung Cell. Mol. Physiol. 283:L256-L264.
28. Segovia J, et al. 2012. TLR2/MyD88/NF-kappaB pathway, reactive oxygen species, potassium efflux activates NLRP3/ASC inflammasome during respiratory syncytial virus infection. PLoS One 7:e29695. doi:10.1371/ journal.pone.0029695.
29. Vassallo R, Standing J, Limper AH. 1999. Beta-glucan from Pneumocystis carinii stimulates TNF alpha release from alveolar macrophages. J. Eukaryot. Microbiol. 46:145S.
30. Wang J, Gigliotti F, Bhagwat SP, Maggirwar SB, Wright TW. 2007. Pneumocystis stimulates MCP-1 production by alveolar epithelial cells through a JNK-dependent mechanism. Am. J. Physiol. Lung Cell. Mol. Physiol. 292:L1495-L1505.
31. Wang J, et al. 2005. Pneumocystis carinii activates the NF-kappaB signaling pathway in alveolar epithelial cells. Infect. Immun. 73:2766-2777.
32. Werts C, et al. 2001. Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism. Nat. Immunol. 2:346-352.
33. Wright TW, et al. 1999. Immune-mediated inflammation directly impairs pulmonary function, contributing to the pathogenesis of Pneumocystis carinii pneumonia. J. Clin. Invest. 104:1307-1317.
34. Wright TW, Johnston CJ, Harmsen AG, Finkelstein JN. 1997. Analysis of cytokine mRNA profiles in the lungs of Pneumocystis carinii-infected mice. Am. J. Respir. Cell Mol. Biol. 17:491-500.
35. Wright TW, Johnston CJ, Harmsen AG, Finkelstein JN. 1999. Chemokine gene expression during Pneumocystis carinii-driven pulmonary inflammation. Infect. Immun. 67:3452-3460.
36. Wright TW, et al. 2004. TNF receptor signaling contributes to chemokine secretion, inflammation, and respiratory deficits during Pneumocystis pneumonia. J. Immunol. 172:2511-2521.
37. Yamamoto M, et al. 2003. Role of adaptor TRIF in the MyD88independent Toll-like receptor signaling pathway. Science 301:640-643.
38. Yoneda K, Walzer PD. 1983. Attachment of Pneumocystis carinii to type I alveolar cells studied by freeze-fracture electron microscopy. Infect. Immun. 40:812-815.
39. Yoneda K, Walzer PD. 1980. Interaction of Pneumocystis carinii with host lungs: an ultrastructural study. Infect. Immun. 29:692-703.
40. Zhang C, et al. 2006. Toll-like receptor 2 mediates alveolar macrophage response to Pneumocystis murina. Infect. Immun. 74:1857-1864.